Request for Information (RFI): Needs and Challenges in Obtaining and Testing Clinical-Grade RNA-based Cancer Vaccine Formulations to Support Translational and Clinical Research

Organization
NCI
Type
NIH RFI
Application Due Date
06-30-2023
Number
NOT-CA-23-063
Brief Description

Purpose

The National Cancer Institute (NCI) is seeking broad input from persons and entities with interest, expertise, and experience in the development of novel RNA-based vaccines for cancer treatment and/or prevention. The NCI is seeking this input to inform future resource allocation and acquisition strategies that can accelerate the development, availability, and evaluation of such agents. Input is requested that will inform both pre-clinical and clinical testing of novel RNA-based cancer vaccines.